文献速递肺外科

电视辅助胸腔镜肺段切除术与肺叶切除术治疗pT1c pN0非小细胞肺癌的局部控制与短期结局

Local control and short-term outcomes after video-assisted thoracoscopic surgery segmentectomy versus lobectomy for pT1c pN0 non-small-cell lung cancer.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2023-01-01

多中心回顾性研究纳入2014年1月至2021年10月连续接受电视辅助胸腔镜肺叶切除术(VL)或肺段切除术(VS)的pT1c pN0非小细胞肺癌患者各81例,比较短期结局与局部控制。VS组拔管时间和术后住院更短,VL组肿瘤更大且淋巴结清扫数更多;随访中位31个月时两组局部和远处复发率及总生存率无统计学差异。

要点

  • 30天术后并发症发生率VL组34% vs VS组30%,P=0.5,无统计学差异。
  • 拔管中位时间VL组3天 vs VS组2天,术后住院中位时间VL组6天 vs VS组5天,均支持VS组。
  • 随访中位31个月,局部和远处复发VL组12.3% vs VS组6.1%,P=0.183,无统计学差异。

核心结论

  • 尽管随访时间短,初步数据显示VL与VS的局部控制相当。

研究设计与样本

  • 多中心回顾性研究,连续纳入2014年1月至2021年10月接受VATS肺叶切除术(VL,n=81)或VATS肺段切除术(VS,n=81)的pT1c pN0非小细胞肺癌患者,共162例,比较患者特征、术后结局和生存。

主要发现

  • VL组与VS组年龄中位数分别为68(60-73)岁 vs 71(65-76)岁,P=0.034;既往癌症史分别为32% vs 48%,P=0.038;其余人口学与合并症无差异。
  • 30天术后总并发症发生率VL组34% vs VS组30%,P=0.5。
  • 拔管中位时间VL组3(1-5)天 vs VS组2(1-3)天,P=0.002;术后住院中位时间VL组6(4-9)天 vs VS组5(3-7)天,P=0.039。
  • 肿瘤平均大小VL组25.1±3.1 mm vs VS组23.6±3.1 mm,P=0.001;淋巴结清扫中位数VL组14(9-23)枚 vs VS组10(6-15)枚,P<0.001。
  • 随访中位31(14-48)个月,局部和远处复发VL组12.3% vs VS组6.1%,P=0.183;总生存率VL组80% vs VS组80%,P=0.166。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文自述随访时间短。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this study was to compare short-term outcomes and local control in pT1c pN0 non-small-cell lung cancer that were intentionally treated by video-assisted thoracoscopic surgery (VATS) lobectomy or segmentectomy. METHODS: Multicentre retrospective study of consecutive patients undergoing VATS lobectomy (VL) or VATS segmentectomy (VS) for pT1c pN0 non-small-cell lung cancer from January 2014 to October 2021. Patients' characteristics, postoperative outcomes and survival were compared. RESULTS: In total, 162 patients underwent VL (n = 81) or VS (n = 81). Except for age [median (interquartile range) 68 (60-73) vs 71 (65-76) years; P = 0.034] and past medical history of cancer (32% vs 48%; P = 0.038), there was no difference between VL and VS in terms of demographics and comorbidities. Overall 30-day postoperative morbidity was similar in both groups (34% vs 30%; P = 0.5). The median time for chest tube removal [3 (1-5) vs 2 (1-3) days; P = 0.002] and median postoperative length of stay [6 (4-9) vs 5 (3-7) days; P = 0.039] were in favour of the VS group. Significantly larger tumour size (mean ± standard deviation 25.1 ± 3.1 vs 23.6 ± 3.1 mm; P = 0.001) and an increased number of lymph nodes removal [median (interquartile range) 14 (9-23) vs 10 (6-15); P < 0.001] were found in the VL group. During the follow-up [median (interquartile range) 31 (14-48) months], no statistical difference was found for local and distant recurrence in VL groups (12.3%) and VS group (6.1%) (P = 0.183). Overall survival (80% vs 80%) was comparable between both groups (P = 0.166). CONCLUSIONS: Despite a short follow-up, our preliminary data shows that local control is comparable for VL and VS.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Forster C, Abdelnour-Berchtold E, Bédat B, et al. Local control and short-term outcomes after video-assisted thoracoscopic surgery segmentectomy versus lobectomy for pT1c pN0 non-small-cell lung cancer. Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 36856745. doi:10.1093/icvts/ivad037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。